Global Peptide Receptor Radionuclide Therapy (PRRT) Market Growth (Status and Outlook) 2022-2028
- LP 4814603
- 60 Pages
- February 2022
- Pharmaceuticals
The United States Peptide Receptor Radionuclide Therapy (PRRT) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Peptide Receptor Radionuclide Therapy (PRRT) market, reaching US$ million by the year 2028. As for the Europe Peptide Receptor Radionuclide Therapy (PRRT) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Peptide Receptor Radionuclide Therapy (PRRT) players cover Novartis, ITM Solucin, National Institutes of Health, and Australasian Gastro-Intestinal Trials Group, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Receptor Radionuclide Therapy (PRRT) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Gastroenteropancreatic Neuroendocrine Tumor
Foregut Neuroendocrine Tumor
Midgut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis
ITM Solucin
National Institutes of Health
Australasian Gastro-Intestinal Trials Group
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2017-2028
2.1.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Peptide Receptor Radionuclide Therapy (PRRT) Segment by Type
2.2.1 Gastroenteropancreatic Neuroendocrine Tumor
2.2.2 Foregut Neuroendocrine Tumor
2.2.3 Midgut Neuroendocrine Tumor
2.2.4 Hindgut Neuroendocrine Tumor
2.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
2.3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2022)
2.4 Peptide Receptor Radionuclide Therapy (PRRT) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
2.5.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2022)
3 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Player
3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Players
3.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Players (2020-2022)
3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Players (2020-2022)
3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Peptide Receptor Radionuclide Therapy (PRRT) by Regions
4.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions (2017-2022)
4.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2017-2022)
4.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2017-2022)
4.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2017-2022)
4.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022)
5.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022)
5.3 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2017-2022)
6.2 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022)
6.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) by Country (2017-2022)
7.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022)
7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) by Region (2017-2022)
8.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022)
8.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Regions (2023-2028)
10.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Regions (2023-2028)
10.1.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.1.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.1.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.1.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Country (2023-2028)
10.2.1 United States Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.2.2 Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.2.3 Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.2.4 Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Region (2023-2028)
10.3.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.2 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.3 Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.4 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.5 India Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.3.6 Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Country (2023-2028)
10.4.1 Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.2 France Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.3 UK Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.4 Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.4.5 Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Region (2023-2028)
10.5.1 Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.2 South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.3 Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.4 Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.5.5 GCC Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
10.6 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Type (2023-2028)
10.7 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 ITM Solucin
11.2.1 ITM Solucin Company Information
11.2.2 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.2.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 ITM Solucin Main Business Overview
11.2.5 ITM Solucin Latest Developments
11.3 National Institutes of Health
11.3.1 National Institutes of Health Company Information
11.3.2 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.3.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 National Institutes of Health Main Business Overview
11.3.5 National Institutes of Health Latest Developments
11.4 Australasian Gastro-Intestinal Trials Group
11.4.1 Australasian Gastro-Intestinal Trials Group Company Information
11.4.2 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
11.4.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Australasian Gastro-Intestinal Trials Group Main Business Overview
11.4.5 Australasian Gastro-Intestinal Trials Group Latest Developments
12 Research Findings and Conclusion
Table 1. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Gastroenteropancreatic Neuroendocrine Tumor
Table 3. Major Players of Foregut Neuroendocrine Tumor
Table 4. Major Players of Midgut Neuroendocrine Tumor
Table 5. Major Players of Hindgut Neuroendocrine Tumor
Table 6. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2022)
Table 9. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2022)
Table 12. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Player (2020-2022)
Table 14. Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Products Offered
Table 15. Peptide Receptor Radionuclide Therapy (PRRT) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Regions (2017-2022)
Table 20. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country (2017-2022)
Table 22. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2022)
Table 24. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2022)
Table 26. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2017-2022)
Table 28. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2022)
Table 30. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2022)
Table 32. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country (2017-2022)
Table 34. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2022)
Table 36. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Peptide Receptor Radionuclide Therapy (PRRT)
Table 45. Key Market Challenges & Risks of Peptide Receptor Radionuclide Therapy (PRRT)
Table 46. Key Industry Trends of Peptide Receptor Radionuclide Therapy (PRRT)
Table 47. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Application (2023-2028)
Table 53. Novartis Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 54. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 55. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Novartis Main Business
Table 57. Novartis Latest Developments
Table 58. ITM Solucin Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 59. ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 60. ITM Solucin Main Business
Table 61. ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. ITM Solucin Latest Developments
Table 63. National Institutes of Health Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 64. National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 65. National Institutes of Health Main Business
Table 66. National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. National Institutes of Health Latest Developments
Table 68. Australasian Gastro-Intestinal Trials Group Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 69. Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 70. Australasian Gastro-Intestinal Trials Group Main Business
Table 71. Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Australasian Gastro-Intestinal Trials Group Latest Developments
List of Figures
Figure 1. Peptide Receptor Radionuclide Therapy (PRRT) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type in 2021
Figure 7. Peptide Receptor Radionuclide Therapy (PRRT) in Hospital Pharmacies
Figure 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Peptide Receptor Radionuclide Therapy (PRRT) in Retail Pharmacies
Figure 10. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Peptide Receptor Radionuclide Therapy (PRRT) in Online Pharmacies
Figure 12. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application in 2021
Figure 14. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Player in 2021
Figure 15. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2017-2022 ($ Millions)
Figure 17. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2017-2022 ($ Millions)
Figure 18. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2017-2022 ($ Millions)
Figure 20. Americas Peptide Receptor Radionuclide Therapy (PRRT) Value Market Share by Country in 2021
Figure 21. Americas Peptide Receptor Radionuclide Therapy (PRRT) Consumption Market Share by Type in 2021
Figure 22. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application in 2021
Figure 23. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region in 2021
Figure 28. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application in 2021
Figure 29. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country in 2021
Figure 36. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type in 2021
Figure 37. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application in 2021
Figure 38. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application in 2021
Figure 46. Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 52. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 53. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 55. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 56. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 59. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 60. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 61. Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 63. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 64. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 65. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 66. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 67. UK Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 68. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 69. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 70. Spain Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 73. Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
